Evidence map›Paper›PMID 38620125›Full record

ArticleEngineering applications of artificial intelligence2023

A new hybrid prediction model of COVID-19 daily new case data.

Guohui Li, Jin Lu, Kang Chen, Hong Yang

Abstract read
In one paragraph

Article in Engineering applications of artificial intelligence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Guohui LiSchool of Electronic Engineering, Xi'an University of Posts and Telecommunications, Xi'an, Shaanxi 710121, China.
Jin LuSchool of Electronic Engineering, Xi'an University of Posts and Telecommunications, Xi'an, Shaanxi 710121, China.
Kang ChenSchool of Electronic Engineering, Xi'an University of Posts and Telecommunications, Xi'an, Shaanxi 710121, China.
Hong YangSchool of Electronic Engineering, Xi'an University of Posts and Telecommunications, Xi'an, Shaanxi 710121, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the emergence of new mutant corona virus disease 2019 (COVID-19) strains such as Delta and Omicron, the number of infected people in various countries has reached a new high. Accurate prediction of the number of infected people is of far-reaching sig Nificance to epidemiological prevention in all countries of the world. In order to improve the prediction accuracy of COVID-19 daily new case data, a new hybrid prediction model of COVID-19 is proposed, which consists of four modules: decomposition, complexity judgment, prediction and error correction. Firstly, singular spectrum decomposition is used to decompose the COVID-19 data into singular spectrum components (SSC). Secondly, the complexity judgment is innovatively divided into high-complexity SSC and low-complexity SSC by neural network estimation time entropy. Thirdly, an improved LSSVM by GODLIKE optimization algorithm, named GLSSVM, is proposed to improve its prediction accuracy. Then, each low-complexity SSC is predicted by ARIMA, and each high-complexity SSC is predicted by GLSSVM, and the prediction error of each high-complexity SSC is predicted by GLSSVM. Finally, the predicted results are combined and reconstructed. Simulation experiments in Japan, Germany and Russia show that the proposed model has the highest prediction accuracy and the lowest prediction error. Diebold Mariano (DM) test is introduced to evaluate the model comprehensively. Taking Japan as an example, compared with ARIMA prediction model, the RMSE, average error and MAPE of the proposed model are reduced by 93.17%, 91.42% and 81.20% respectively.

Indexed as

COVID-19Daily new caseLeast square support vector machinePredictionSingular spectrum decomposition

Identifiers

PMID38620125
PMCPMC10291292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.